Inspire Medical Systems (INSP) Return on Capital Employed (2018 - 2026)

Inspire Medical Systems has disclosed Return on Capital Employed across 9 years of filings, most recently posting 6.26% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 6.26%, down 80.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.26% (down 80.0% YoY), and the FY2025 annual result was 6.69%, up 117.0% from the prior year.
• Return on Capital Employed came in at 6.26% for Q1 2026 at Inspire Medical Systems, down from 6.69% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.05% in Q1 2025 to a low of 17.08% in Q2 2022.
• The 5-year median for Return on Capital Employed is 5.91% (2024), against an average of 3.67%.
• Across the five-year window, Return on Capital Employed surged 1296 bps in 2025 and sank 80 bps in 2026, its largest moves.
• Inspire Medical Systems' Return on Capital Employed stood at 9.81% in 2022, then increased by 29 bps to 6.94% in 2023, then jumped by 173 bps to 5.06% in 2024, then surged by 32 bps to 6.69% in 2025, then decreased by 6 bps to 6.26% in 2026.
• The last three Return on Capital Employed figures came in at 6.26% (Q1 2026), 6.69% (Q4 2025), and 5.29% (Q3 2025), per Business Quant data.